Shelter Pharma (BOM:543963) Debt-to-Revenue : 0.01 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Shelter Pharma Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Shelter Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹0.0 Mil. Shelter Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₹5.7 Mil. Shelter Pharma's annualized Revenue for the quarter that ended in Mar. 2024 was ₹414.2 Mil. Shelter Pharma's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 was 0.01.

Shelter Pharma Debt-to-Revenue Historical Data

The historical data trend for Shelter Pharma's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shelter Pharma Debt-to-Revenue Chart

Shelter Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Debt-to-Revenue

0.05

0.01

Shelter Pharma Semi-Annual Data
	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Revenue	Get a 7-Day Free Trial			N/A	-	0.05	0.01	0.01

Competitive Comparison of Shelter Pharma's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shelter Pharma's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Shelter Pharma's Debt-to-Revenue falls into.

Shelter Pharma Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Shelter Pharma's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.041	+	5.732)	/	400.2
	=	0.01

Shelter Pharma's annualized Debt-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.041	+	5.732)	/	414.16
	=	0.01

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Mar. 2024) Revenue data.

Shelter Pharma Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shelter Pharma's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shelter Pharma (BOM:543963) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shelter Pharma Ltd (BOM:543963) » Definitions » Debt-to-Revenue

Traded in Other Exchanges

N/A

Address

Mistry Chambers, Khanpur, Ahmedabad, GJ, IND, 380001

Website

https://www.shelter.co.in

Shelter Pharma Ltd focuses in manufacturing herbal products with well-built presence in Human Pharma as well as Veterinary space. It is present in most of non-critical segment of Human as well as Veterinary Pharma through its well spread portfolio. Its products include Tablets, syrups, Baby drops, Barley Water, Oils, Powders, Ointments and Etc.

Shelter Pharma (BOM:543963) Headlines

No Headlines